Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study
about
Bone and TNF in rheumatoid arthritis: clinical implicationsEffects of anti-tumor necrosis factor α agents on boneMeta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsEstablishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen OsteoDoes digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: subanalysis of the PREMIER study.Bone mineral density by digital X-ray radiogrammetry is strongly decreased and associated with joint destruction in long-standing rheumatoid arthritis: a cross-sectional studyEvaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial.Early metacarpal bone mineral density loss using digital x-ray radiogrammetry and 3-tesla wrist MRI in established rheumatoid arthritis: a longitudinal one-year observational study.Alternative for anti-TNF antibodies for arthritis treatment.Long-term in-vitro precision of direct digital X-ray radiogrammetry.Is there a role for Digital X-ray Radiogrammetry as surrogate marker for radiological progression and imaging of structural integrity in rheumatoid arthritis?Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modificationUsing hand bone mass measurements to assess progression of rheumatoid arthritis.Protective effects of tumor necrosis factor-α blockade by adalimumab on articular cartilage and subchondral bone in a rat model of osteoarthritisCytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?Periarticular osteoporosis is a prominent feature in early rheumatoid arthritis: estimation using shaft to periarticular bone mineral density ratioInitiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesEffects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.Efficient and Non-Toxic Biological Response Carrier Delivering TNF-α shRNA for Gene Silencing in a Murine Model of Rheumatoid Arthritis.Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target StrategyLong-term use of adalimumab in the treatment of rheumatic diseases.Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.Value of digital X-ray radiogrammetry in the assessment of inflammatory bone loss in rheumatoid arthritis.Digital X-ray radiogrammetry and its sensitivity and specificity for the identification of rheumatoid arthritis-related cortical hand bone loss.Measuring metacarpal cortical bone by digital x-ray radiogrammetry: a step forward?Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy.Risk factors for bone loss in patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort.Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.Visualisation of structural damage as a surrogate marker of radiographic progression in patients with rheumatoid arthritis.
P2860
Q26777895-3FCA0CE1-6ADC-4E87-B063-DD0E1018CF45Q26851274-45EE31BF-7DBA-455D-A5F5-0ACA48BAED21Q27025358-15015627-7D9B-4670-B786-E2659AC5824EQ28603734-D016B65E-C5CA-40AE-B6D5-CB7C90D0D503Q33766248-C4F4D9BB-EFFF-42E6-AC40-4DEEF097D656Q33830219-E2788BE9-5B63-4728-BC10-E187E47DEEEEQ34056836-59661B64-8989-4D3C-8D18-47F6995EF00EQ34622578-B1B53F3C-8E44-47A8-9AA6-94D359A631B2Q35138304-C95AAE86-8096-443B-84DD-AD8B5E9E6988Q35285800-8427CD59-BDBB-418A-85A1-0A83131979F1Q35406800-EFC280B6-E059-48D3-8DED-441A1FD3C456Q35671122-A2CCA034-D5F8-480B-8998-FA74732F00A3Q36020188-FF26DCFF-9AFD-4347-A6B6-0599D66A46F6Q36059378-0029BFC1-F048-4D0E-AD19-2ED8923345FBQ36196730-EFFE1126-DB93-4E9D-9C7B-1531D449E343Q36245722-B7DBB952-83BE-4CF6-8EF9-0F502B406969Q36589519-FBC6DAEC-B393-49F3-A028-8B488F00B734Q36781280-354733BE-236B-4FED-AC76-CC1C164C4339Q37051820-E82429DB-D53E-4DEF-B800-384F4E536295Q37188068-BEC1942D-B80F-43A5-99B7-A85C177917B5Q37206416-249DFB5E-87E7-47B2-9F6E-24A90E43B677Q37358124-42354D4D-7875-43F5-86F4-27A4832A4B02Q37801555-2201C82D-9C50-4DF0-9383-3AA8E5A69E2EQ39127801-00D57C37-4340-43A6-A782-DFFDB7A3446BQ39982542-229837E9-6E66-4CD2-B68A-04A96F62D4A6Q40359776-5CCF6B5D-CB47-4C72-ABC1-88999E62BC05Q42692903-FFDB3C09-A0F5-4F99-9096-CCBCDBD1A541Q44794499-BB118AAB-E785-4875-8812-FEFC368CE2ECQ47110800-458E1034-2A67-4AF6-844D-FAF22F06D1F4Q48503661-5CF80FC7-9A06-4F66-956F-B56FFC59DE51Q53085402-14BE2729-41E6-431B-B7FD-893C215E9418Q54620277-DC9E5E80-0DEA-44BC-B0CC-F83AAC94A06A
P2860
Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adalimumab therapy reduces han ...... nalyses from the PREMIER study
@en
Adalimumab therapy reduces han ...... alyses from the PREMIER study.
@nl
type
label
Adalimumab therapy reduces han ...... nalyses from the PREMIER study
@en
Adalimumab therapy reduces han ...... alyses from the PREMIER study.
@nl
prefLabel
Adalimumab therapy reduces han ...... nalyses from the PREMIER study
@en
Adalimumab therapy reduces han ...... alyses from the PREMIER study.
@nl
P2093
P2860
P356
P1476
Adalimumab therapy reduces han ...... nalyses from the PREMIER study
@en
P2093
P2860
P304
P356
10.1136/ARD.2008.091264
P407
P577
2008-09-18T00:00:00Z